Presented by

NEWS
wow (part 2)

Welcome to today’s actual Daily Rip, not the test version our team accidentally sent out this morning. We all make mistakes, though the power of the publish button hits a bit differently when there are over a million people on the other side of it. 🤣 

Nevertheless, it was a busy day on Wall Street, and we’ve got you covered. Stock market bulls are still searching for a catalyst amid economic and geopolitical uncertainty. Meanwhile, precious metal bulls are running wild as gold hits a new all-time high, and silver prices hit their highest level since 2011. 👀 

Today's issue covers why bulls can’t catch a break, GameStop and other big movers, and more of the most notable stories from the day. 📰

Here’s the S&P 500 heatmap. 3 of 11 sectors closed green, with consumer staples (+1.14%) leading and energy (-0.97%) lagging.

And here are the closing prices: 

STOCKS
Bulls Can’t Catch A Break 🫠 

With the market indexes struggling to reclaim their 200-day moving averages, bulls are waiting for a catalyst. However, on the economic front, Lululemon’s holiday-quarter results raised further red flags about the state of the U.S. consumer.

The athletic apparel company’s earnings per share and revenue both topped estimates, but its guidance failed to impress. CFO Meghan Frank signaled that gross margin for 2025 is expected to fall 0.6 percentage points due to higher fixed costs, foreign exchange rates, and U.S. tariffs on China and Mexico. 🔻 

CEO Calvin McDonald said a company survey found that consumers are spending less due to economic and inflation concerns, weighing on U.S. traffic at its stores and industry peers. “There continues to be considerable uncertainty driven by macro and geopolitical circumstances. That being said, we remain focused on what we can control.” 

Shares fell by as much as 20% after hours, but have recovered roughly half that decline as of writing this. Stocktwits sentiment is now ‘extremely bearish.’ 🐻 

Overall market sentiment is subdued, as indicated by the progress of Nvidia-backed CoreWeave’s IPO. Nvidia signaled that it was looking to anchor the IPO by purchasing $250 million of stock at $40 per share. With the company initially aiming for $47 to $55, investors now know the final offering price will fall short.

If this hype-heavy AI stock can’t find its footing in tomorrow’s Nasdaq debut, bears will use that as an opportunity to build on the market’s pessimism. And right now, our poll indicates many retail investors will be avoiding it altogether. 😬 

SPONSORED
OS Therapies (NYSE: $OSTX) is advancing OST-HER2, its novel immunotherapy.

OS Therapies (NYSE: $OSTX) is advancing OST-HER2, a novel immunotherapy targeting HER2-positive cancer cells. In osteosarcoma, the most common form of bone cancer, OST-HER2 has completed a Phase 2b clinical trial focused on preventing lung metastases, the leading cause of mortality in these patients.

OST-HER2 has received Rare Pediatric Disease Designation (RPDD) from the FDA, underscoring the urgent need for treatment options and creating a pathway to a Priority Review Voucher (PRV) upon approval. PRVs, which are transferable and have historically sold for ~$150M, are an incentive to encourage investment in rare disease research.

OS Therapies plans to submit a Biologics License Application (BLA) in late 2025 to pursue FDA approval and a potential PRV by year-end. The Company is also preparing a Phase 2/3 trial in breast cancer and other HER2-positive solid tumors, set to begin in 2026.

OS Therapies (NYSE: $OSTX) is a B2i Digital Featured Company.

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.